Literature DB >> 19433225

Synthesis, physicochemical and immunological properties of oxidized inulin-L-asparaginase bioconjugate.

Mohammad Reza Tabandeh1, Mahmood Aminlari.   

Abstract

In recent years several bioconjugation protocols have been developed to improve the pharmacokinetic and immunological properties of anti-leukemic enzyme, L-asparaginase. In this study we investigated the effect of conjugation with oxidized inulin on these properties. Inulin (MW about 25kDa) was oxidized with periodate and was conjugated to the enzyme at molar ratios of oxidized inulin to enzyme between 2:1 and 4:1. Modified L-asparaginase synthesized at ratio of 2:1 had activity of 65% of that of native enzyme and was used in subsequent experiments. The apparent K(m) of glycoconjugate (0.1 x 10(-4)M) was about five times lower than the K(m) of native enzyme (0.57 x 10(-4)M). Modified L-asparaginase had longer half life, higher thermostability and more resistance to trypsin digestion and better reusability after repeated freezing and wider optimum pH range than that of intact L-asparaginase. The modification of L-asparaginase with oxidized inulin at molar ratio of 2:1 resulted in decreasing antibody (IgG) titer and immunogenecity after repeated injection of rabbits with respect to the native L-asparaginase. Taken together, the results of this study indicated that L-asparaginase modification by oxidized inulin results in a new stabilized product with improved biochemical properties which may be employed for medical purposes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19433225     DOI: 10.1016/j.jbiotec.2009.03.020

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  7 in total

1.  Expression and Functional Characterization of Pseudomonas aeruginosa Recombinant L.Asparaginase.

Authors:  Hesham Saeed; Hadeer Soudan; Amany El-Sharkawy; Aida Farag; Amira Embaby; Farid Ataya
Journal:  Protein J       Date:  2018-10       Impact factor: 2.371

2.  Molecular characterization and functional activity of an IL-15 antagonist MutIL-15/Fc human fusion protein.

Authors:  Xiaoyi Yang; Abraham Kallarakal; Nirmala Saptharishi; Hengguang Jiang; Zhiwen Yang; Yueqing Xie; George Mitra; Xin Xiao Zheng; Terry B Strom; Gopalan Soman
Journal:  Mol Pharm       Date:  2013-01-22       Impact factor: 4.939

3.  Purification and Characterization of Glutaminase Free Asparaginase from Enterobacter cloacae: In-Vitro Evaluation of Cytotoxic Potential against Human Myeloid Leukemia HL-60 Cells.

Authors:  Islam Husain; Anjana Sharma; Suresh Kumar; Fayaz Malik
Journal:  PLoS One       Date:  2016-02-18       Impact factor: 3.240

4.  Cloning and expression of L-asparaginase from Bacillus tequilensis PV9W and therapeutic efficacy of Solid Lipid Particle formulations against cancer.

Authors:  Ganeshan Shakambari; Rai Sameer Kumar; Balasubramaniem Ashokkumar; Venkatachalam Ganesh; Vairathevar Sivasamy Vasantha; Perumal Varalakshmi
Journal:  Sci Rep       Date:  2018-12-20       Impact factor: 4.379

5.  Influence of Oxidation Degree on the Physicochemical Properties of Oxidized Inulin.

Authors:  Franklin Afinjuomo; Paris Fouladian; Thomas G Barclay; Yunmei Song; Nikolai Petrovsky; Sanjay Garg
Journal:  Polymers (Basel)       Date:  2020-05-01       Impact factor: 4.329

Review 6.  Development of L-Asparaginase Biobetters: Current Research Status and Review of the Desirable Quality Profiles.

Authors:  Larissa Pereira Brumano; Francisco Vitor Santos da Silva; Tales Alexandre Costa-Silva; Alexsandra Conceição Apolinário; João Henrique Picado Madalena Santos; Eduardo Krebs Kleingesinds; Gisele Monteiro; Carlota de Oliveira Rangel-Yagui; Brahim Benyahia; Adalberto Pessoa Junior
Journal:  Front Bioeng Biotechnol       Date:  2019-01-10

7.  Superior operational stability of immobilized L-asparaginase over surface-modified carbon nanotubes.

Authors:  Mafalda R Almeida; Raquel O Cristóvão; Maria A Barros; João C F Nunes; Rui A R Boaventura; José M Loureiro; Joaquim L Faria; Márcia C Neves; Mara G Freire; Valéria C Santos-Ebinuma; Ana P M Tavares; Cláudia G Silva
Journal:  Sci Rep       Date:  2021-11-02       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.